Chinook Therapeutics Investor Relations Material
Latest events
Investor Update
Chinook Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Chinook Therapeutics Inc
Access all reports
Chinook Therapeutics Inc (Chinook) is a clinical-stage biotechnology company focused on the discovery and development of precision medicines for kidney diseases. The Company's product pipeline comprises of novel drug candidates in various stages of development for the treatment of kidney disease associated with type 2 diabetes. Chinook Therapeutics Inc. is headquartered in Seattle, Washington.
Key slides for Chinook Therapeutics Inc
Investor Presentation
Chinook Therapeutics Inc
Investor Presentation
Chinook Therapeutics Inc
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States